 So this was actually scheduled to be like a live event that the site would be launched from here, but the time changed on Sunday. So it's seven o'clock in New York and people didn't want to stay until seven. So they just launched the site at six p.m. there, which was an hour ago. So I think it's good enough. So here, so this is the website for the new journal that just came live, as I said, was gonna come live straight from here, but came live one hour ago worldwide. So that's the main webpage of the journal. These are the three papers that have already been submitted. So I'll give a very quick view and then I'll go slowly over each component. So they wanted a picture that represented translation and I'll tell you how I came up with this picture. So, and then they also did a press release, the Nature Group did, which is about both the conference and the launching of the journal. So the conference was, they're putting here the, so if you go here, you go straight to our program. And so the site, if you go to look at papers or to submit something, the latest articles are here, but there are only three that just came live now. There would be an archive for all the papers. Press releases would be here. So let's see, I think they have a press release about the journal itself. So here's the launch of the journal, which is in New York for, is right now. It's the end of the day for them on the April 4th. So I mean, you can see all of this for yourself on the website. So this is basically describing the journal and why we need it and emphasizing here the translation psychiatry bridges the gap between discovery and healthcare by fostering, highlighting the pathway from discovery to clinical applications, healthcare and global health. So in the website itself, if people want to submit papers, you have here this online submission site that you need to register. And each person, many people who are already published there just have their login and password. If not, you register for an account. You have here author instructions, which is amazing that how people don't read instructions. In this journal specifically, we don't have a letter section because it's a lot of work for me. So people write a letter about the paper. The author didn't see these. The author responds, yes, but I was right anyway, et cetera. And then you can publish the dialogue as a letter to the editor. I think some new formats, they put like a blog and you can put the comments on the side like PLOS does that in the other PLOS journals. But a formal like traditional letter to the editor section is a lot of work and then you have to coordinate publication and then they have to come up more or less closer to the time that the paper came. So I didn't think it was a good use of time but in spite of that, we recently had a letter to the editor submitted. So the person called it an original research article but you read this a letter to the editor. And we have very explicit instructions not to have that. So here, I'm not gonna do this but you can click here and get the instructions. So the key manuscript types are original research articles and reveals without these short letters that either comment on papers or people put like a mini article there. So this thing of instructions, I think it's very illustrative for people dealing with traditional media, new media, which is very annoying to people who are processing the papers when the person who's doing the submission shows that they haven't even looked at the instructions that aren't familiar with the journal. So molecular psychiatry, the abstract is what we call and this translation of psychiatry as well, both of them. The abstract is just a single paragraph. It's unstructured. So you just write 200 words, 250 words, summarizing everything. There is no section. Like in some journals like German now, for example, they put introduction. I think that the PLOS journals, you have introduction. Methods, results, conclusion. We don't have those sections, never had them. So people sent to me the papers formatted like that. It annoys me so much because it shows that they don't know the journal. They've never looked at the journal. They didn't read the instructions and they just don't care. They send it somewhere that had that requirement. It was not accepted. And then they just, you know, shipped it to me without the courtesy of reformatting per the journal standards. So it's very annoying. So people should please read the instructions for others. Then the three papers that came already is my own editorial that was printed and people gave a copy. Tom Minsell, who is the director of the National Institute of Mental Health at the NIH, he published this editorial here. So he wrote, he called this new journal a bridge to somewhere. And it says with over 5,000 journals indexed in PubMed, the announcement of a new journal generally elicits a raised brow along with some variation on these questions. Do we need another journal? Who can read even 10% of the journals covering neuropsychiatric science in the basic clinic? Will more journals just permit more publishing of mediocre science? And the answer depends on the journal or more specifically on the topic. And then he goes here to talk about the importance of translational psychiatry. And he said what I said yesterday as well, which is that in 2011, none of these findings from the last several decades are changing how clinicians diagnose or treat serious mental illness. And although neuroimaging has given us a window into brain development, connectivity and its function, is there any scan that reliably influences clinical care? And even though that Alzheimer's can be diagnosed by imaging now, it doesn't really change the course of dementia. So he puts, does a little propaganda highlighting some NIMAGE funded projects that have potential for translation. And then he essentially talks about the field. One thing which is interesting is that as he describes translation, he calls, he uses the terms T1 to T2 and T3 that I described yesterday. And but he stops there. So what I call the T0 and T4 and T5, it's not conceptualized by many other people yet. So the way he puts T1 going from discovery to the clinic, to from T2, the clinical trials. And then T3 he talks about, let's say even if 20,000 pet scan could reliably diagnose bipolar disorder. So that would be a T1 discovery. And even if this could show to work in a real world clinic, so that would be a T2 discovery. So some clinical trial show that it did work in the clinic. Would this scan be reimbursed by payers or required by guidelines? So that would be T3. And he kind of stops there. So he was very complimentary. And he says that the journal has an opportunity to make a difference by publishing the best science at the time when we can see this historic bridge being built that will link science, practice, and policy. And he says, I for one will watch and read it with enthusiasm. So that was very nice. And we had one, we have like two or three additional, actually seven papers that are about to be put on the line, but the one that came out an hour ago, the first one was this one, which was very interesting that vasopressin is a hormone that's been shown to mediate social behavior in animals and in humans. And it's been considered like a target for genetic studies in autism. So they apply these authors who are from the NIH and from Germany, from the NIH in Germany. They applied a functional MRI test with a social recognition masking task. And then they used a double-blind procedure that the volunteer himself sprayed intranasally, either with saline or with vasopressin, 45 minutes before the test. And then they looked at brain performance in relation to these social cues. And they showed that vasopressin induces a regional specific alteration in a keynote of the three of my network, the left temporal parietal junction. And they proposed that this could be a neurobiological mechanism for prosocial neuropeptogenic effects in humans that suggest novel treatment strategies. And what's very interesting is that you go to the methods here, so they say that they use this phase stimuli, which is from a standardized setting that has been made available for research. So you can just click here, and you can actually go to the site of the entity that gives this this kind of a set of phase. So people who are in neuropsychology are very familiar with this. So this is the maxbrain.org. And the internet here is kind of slow. So it is downloading slowly, but the battery of phases is here. So this was originally sponsored by the MacArthur Foundation. And if you just patient a little bit, you'll see that they use the, those are the phases that they use. So in the methods of the papers, you can actually cross reference to outside resources. And people who are reading the paper, they don't have to have the resource actually in the paper. You can just use the link. So it's coming here. So these are the phases that come up in the recognition of emotion. And then, and some pictures were taken from the international effective picture system. So you can go there as well and actually see the pictures. So that's one of the advantages of the online, so here is this an IMAGE Center for the Study of Emotion and Attention. And here's where you can get the other pictures that they used. So the beauty of the online systems now for the papers is that you can actually, within the paper, because you know, people were talking yesterday that some people like the texture of the books, et cetera, but doing it online or on iPad or laptop or hard desk computer, you can actually click on the methods and the parts of the paper that you want and then you can see much more information. So here it shows in the figures. And what's interesting is that the new type of paper is gonna come for all journals. It's not gonna be restricted to this one. That you can actually condense and collapse sections of papers. So if you think that the paper's discussion is just a lot of blah, blah, blah, and you're interested in the data, you kind of collapse the discussion and you can enhance the figures, for example. And then you can print your own version or create your own PDF of that. You, essentially, you get the bits and pieces that you want of the paper and you can make your own manuscript based on what the author has there. So you don't have to print like, you know, 20 pages of methods. If you don't care about the methods, you want just the point. You can just click on some, you know, each, like, you know, smoke component of the paper is you can either click a button, it expands, or you click it again and it shortens. And then you create your own version of the paper based on how much or how little you want to see. So that's what I had to do today. We just had one research paper just launched an hour ago in New York and many more are on the pipeline to come. So I thank you very much for being here and I hope you'll visit the site very frequently. Thank you.